Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pazopanib and sunitinib trigger autophagic and non-autophagic death of bladder tumour cells.
Santoni M, Amantini C, Morelli MB, Liberati S, Farfariello V, Nabissi M, Bonfili L, Eleuteri AM, Mozzicafreddo M, Burattini L, Berardi R, Cascinu S, Santoni G. Santoni M, et al. Among authors: farfariello v. Br J Cancer. 2013 Aug 20;109(4):1040-50. doi: 10.1038/bjc.2013.420. Epub 2013 Jul 25. Br J Cancer. 2013. PMID: 23887605 Free PMC article.
Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells.
Amantini C, Morelli MB, Santoni M, Soriani A, Cardinali C, Farfariello V, Eleuteri AM, Bonfili L, Mozzicafreddo M, Nabissi M, Cascinu S, Santoni G. Amantini C, et al. Among authors: farfariello v. Oncoscience. 2015 Mar 23;2(4):395-409. doi: 10.18632/oncoscience.147. eCollection 2015. Oncoscience. 2015. PMID: 26097873 Free PMC article.
TRP channels and cancer: new targets for diagnosis and chemotherapy.
Santoni G, Farfariello V. Santoni G, et al. Among authors: farfariello v. Endocr Metab Immune Disord Drug Targets. 2011 Mar;11(1):54-67. doi: 10.2174/187153011794982068. Endocr Metab Immune Disord Drug Targets. 2011. PMID: 21348820 Review.
TRPV channels in tumor growth and progression.
Santoni G, Farfariello V, Amantini C. Santoni G, et al. Among authors: farfariello v. Adv Exp Med Biol. 2011;704:947-67. doi: 10.1007/978-94-007-0265-3_49. Adv Exp Med Biol. 2011. PMID: 21290335 Review.
35 results